Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 24 of 24 entries
View as:

Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT04465877 Org: User:
Start: 06/15/20 End: 02/17/21 Due: 02/17/22

Study to Evaluate the Safety and Efficacy of JTE-051 in Subjects With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03358290 Org: User:
Start: 11/10/17 End: 10/29/18 Due: 10/29/19

Study to Assess Safety,Tolerability,Pharmacokinetics & Antiviral Activity of JTK-853 in Hepatitis C Virus Genotype 1 Infected Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01473056 Org: User:
Start: 08/31/10 End: 09/30/11 Due: 09/30/12

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252

Phase: N/A Priority: Normal
NCT ID: NCT02120976 Org: User:
Start: 04/30/14 End: 03/31/15 Due: 03/31/16

Two Week Study Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Doses of JTK-853 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01473069 Org: User:
Start: 03/31/10 End: 07/31/10 Due: 07/31/11

Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis

Phase: N/A Priority: Normal
NCT ID: NCT02919475 Org: User:
Start: 09/14/16 End: 06/25/18 Due: 06/25/19

Efficacy and Safety Study of JTT-654 in Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00997152 Org: User:
Start: 09/30/09 End: 04/30/10 Due: 04/30/11

Efficacy and Safety Study of JTT-705 in Combination With Pravastatin 40 mg in Patients With Type II Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT00688896 Org: User:
Start: 06/30/02 End: 03/31/04 Due: 03/31/05

Study to Evaluate Effect of Lapatinib on Pharmacokinetics of JTZ-951 in Subjects With End-stage Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT02581124 Org: User:
Start: 10/31/15 End: 04/30/16 Due: 04/30/17

Study to Evaluate Safety,Tolerability,Pharmacodynamics & Pharmacokinetics of JTE-451 in Active Plaque Psoriasis Subjects

Phase: N/A Priority: Normal
NCT ID: NCT03018509 Org: User:
Start: 12/31/16 End: 06/20/17 Due: 06/20/18

Safety and Efficacy Study of JTT-851 in Patients With Type 2 Diabetes Mellitus

Phase: N/A Priority: Normal
NCT ID: NCT01699737 Org: User:
Start: 09/30/12 End: 07/31/13 Due: 07/31/14

Safety, Tolerability and Pharmacokinetics Study Assessing Ascending Single Oral JTK-853 Doses in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01475981 Org: User:
Start: 01/31/10 End: 04/30/10 Due: 04/30/11

Safety, Tolerability, PK & PD Study of JTZ-951 in Anemic Subjects With End-stage Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT01971164 Org: User:
Start: 05/31/13 End: 07/31/14 Due: 07/31/15

Study of Safety, Tolerability and Pharmacokinetics of Single Oral JTT-251 Doses in Healthy and Type 2 Diabetic Subjects

Phase: N/A Priority: Normal
NCT ID: NCT02106585 Org: User:
Start: 03/31/14 End: 08/31/14 Due: 08/31/15

Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients

Phase: N/A Priority: Normal
NCT ID: NCT00929539 Org: User:
Start: 06/30/09 End: 07/31/10 Due: 07/31/11

Study to Evaluate Efficacy and Safety of JTT-251 in Participants With Pulmonary Arterial Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT03789643 Org: User:
Start: 03/31/19 End: 06/30/21 Due: 06/30/22

Mass Balance Study of JTZ-951 in Subjects With End-stage Renal Disease on Hemodialysis

Phase: N/A Priority: Normal
NCT ID: NCT02805244 Org: User:
Start: 06/30/16 End: 09/30/16 Due: 09/30/17

Safety and Efficacy Study of JTT-705 in Combination With Simvastatin 40 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Phase: N/A Priority: Normal
NCT ID: NCT00688558 Org: User:
Start: 02/29/04 End: 03/31/06 Due: 03/31/07

Safety and Efficacy Study of JTT-705 in Combination With Atorvastatin 20 mg in Patients With Low High-Density Lipoprotein (HDL) Levels

Phase: N/A Priority: Normal
NCT ID: NCT00689442 Org: User:
Start: 01/31/04 End: 03/31/06 Due: 03/31/07

Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Phase: N/A Priority: Normal
NCT ID: NCT00748852 Org: User:
Start: 01/31/07 End: 03/31/08 Due: 03/31/09

Efficacy and Safety Study of JTT-302 in Subjects With Low HDL-C Levels

Phase: N/A Priority: Normal
NCT ID: NCT00749788 Org: User:
Start: 12/31/06 End: 02/29/08 Due: 02/28/09

Study to Evaluate the Efficacy and Safety of JTE-451 in Subjects With Moderate to Severe Plaque Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT03832738 Org: User:
Start: 01/17/19 End: 03/13/20 Due: 03/13/21

Effect of Hemodialysis on the PK of JTZ-951 in Subjects With End-stage Renal Disease

Phase: N/A Priority: Normal
NCT ID: NCT01978587 Org: User:
Start: 10/31/13 End: 01/31/14 Due: 01/31/15

Evaluate Efficacy, Safety and Tolerability of JTT-861 in Subjects With Heart Failure With Reduced Ejection Fraction

Phase: N/A Priority: Normal
NCT ID: NCT06017609 Org: User:
Start: 12/20/23 End: 02/28/27 Due: 02/28/28